| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| July 6, 2010 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | $3.39 | 100,000 | |
| July 29, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | $3.42 | 30,000 | |
| August 10, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,000 | $3.35 | 3,000 | |
| September 16, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.10 | 15,000 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,550 | $3.03 | 28,087 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 100 | $3.04 | 28,187 | |
| December 6, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | $2.81 | 30,000 | |
| January 14, 2011 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 6 | $1,197.80 | 6 | |
| January 14, 2011 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,499 | -- | 2,500 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $1,197.80 | 12 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,999 | -- | 5,000 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 83 | $1,197.80 | 83 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 34,583 | -- | 34,583 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| February 25, 2011 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,000 | $2.49 | 255,000 | |
| February 25, 2011 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | $2.49 | 145,000 | |
| February 25, 2011 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- | 35,000 | |
| February 25, 2011 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,000 | $2.49 | 170,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
